Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 10,781–10,800 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

SODIUM CARBOXYM-CELL PF 0.5% OPHTH, opthalmic, 0.50%, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5mL Glass/Multiple Dose via, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PYRIDOXAL-5-PHOS 5ML MDV 50MG/ML INJ, 50mg/mL, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PYRIDOXAL-5-PHOS 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PROGESTERONE SESAME OIL 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 10mL Glass; Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL SDV 2% INJ, Injection, 2%, Rx only, packaged in 10mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL SDV 1% INJ, Injection, 1%, Rx only, packaged in 5mL and 50 mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL *5ML* SDV SULFITE FREE 1% INJ, Injection, 1%, RXxonly, 5mL Glass/Single Dose vials, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL 50ML MDV (CALIF) 1% INJ, Injection, 1%, Rx only, 50mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL-B12 *10ML* MDV 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

METHYL-B12 5ML MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

MAGNESIUM SO4 10ML MDV 50% INJ, Injection, 50%, Rx only, 10 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

GSH/NAC INH PV 150/50MG/ML SOLN, Inhalation Solution, 150mg/50mg/mL, Rx only, 4mL Plastic/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

GSH/NAC INH 2ML PV 60/100MG/ML SOLN, Inhalation Solution, 60mg/100mg/mL, Rx only, 5mL Plastic/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

GLUTATHIONE INH *PV* 200MG/ML SOLN, Inhalation Solution, 200mg/mL, Rx only, 4mL Plastic/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

IRON SPECIAL 5ML MDV 60/10MG/5MCG/ML INJ, Injection, 60mg/1mg/5mcg/mL, Rx only, 5mL Glass /Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

FERR GLUC MDV 60MG/ML INJ, Injection, 60mg/mL, Rx only, Packaged in 5mL and 10mL Glass /Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

CYANOCOBALAMIN 10ML MDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Drug Recall Terminated Historical recordClass II

CHOL/IN/ME(L)/B6 10ML MDV 50/50/25/0.1MG/ML INJ, Injection, 50mg/50mg/25mg/0.1mg/mL, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Recall initiated
April 18, 2017
Reported by FDA
May 24, 2017
Distribution
Distributed nationwide in U.S.A., Australia and Canada.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.